U. Dirmeier

发表

Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells

S. Mandl, R. Rountree, R. Steigerwald, 2011, Cancer Immunology, Immunotherapy.

Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.

S. Mandl, R. Rountree, A. Delcayre, 2011, Cancer research.

Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.

W. Hammerschmidt, M. Sandberg, G. Reisbach, 2003, Cancer research.

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates

H. Schuitemaker, J. Custers, C. Mire, 2018, PloS one.

A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune Responses

P. Chaplin, J. Hausmann, S. Wennier, 2013, PloS one.

Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-κB Signaling Pathway

Wolfgang Hammerschmidt, Georg W. Bornkamm, Susanne Berchtold, 2003, Journal of Virology.

Latent membrane protein 1 of Epstein–Barr virus coordinately regulates proliferation with control of apoptosis

W. Hammerschmidt, D. Eick, O. Gires, 2005, Oncogene.

Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles

Marc Schweneker, E. Schraner, G. Zimmer, 2017, Journal of Virology.

Stability and suitability for storage and distribution of Ad26.ZEBOV/MVA‐BN®‐Filo heterologous prime‐boost Ebola vaccine

M. Capelle, U. Dirmeier, J. Adriaansen, 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Active NF-kappaB signalling is a prerequisite for influenza virus infection.

L. Staudt, A. Rosenwald, G. Hobom, 2004, The Journal of general virology.

A poxviral-based cancer vaccine targeting the transcription factor Twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer model

Andressa Ardiani, J. Hodge, U. Dirmeier, 2015, Oncotarget.

Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury

J. Schlom, R. Madan, W. Dahut, 2017, Clinical Cancer Research.

Introduction of the Six Major Genomic Deletions of Modified Vaccinia Virus Ankara (MVA) into the Parental Vaccinia Virus Is Not Sufficient To Reproduce an MVA-Like Phenotype in Cell Culture and in Mice

M. Suter, M. Wagner, M. Späth, 2010, Journal of Virology.

Active NFk B signalling is a prerequisite for influenza virus infection

L. Staudt, A. Rosenwald, G. Hobom, 2004 .

The Synechococcus Strain PCC 7942glnN Product (Glutamine Synthetase III) Helps Recovery from Prolonged Nitrogen Chlorosis

K. Forchhammer, U. Dirmeier, Jörg Sauer, 2000, Journal of bacteriology.

Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses

J. Schlom, R. Madan, J. Gulley, 2015, Journal of Immunotherapy for Cancer.

Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells

S. Mandl, R. Rountree, R. Steigerwald, 2011, Cancer Immunology, Immunotherapy.